Real-time enrollment status for this major depressive disorder clinical trial
Current Status
Recruiting
Checked: August 28, 2026 at 9:16 AM UTC
| NCT Number | NCT06633016 |
| Recruiting Status | Recruiting |
| Condition | Major Depressive Disorder |
| Phase | PHASE2 |
| Target Enrollment | 230 participants |
| Active Locations | 50 sites in the US |
| Sponsor | Autobahn Therapeutics, Inc. |
| Last Updated on CT.gov | January 20, 2026 (Jan 20, 2026) |
As of August 28, 2026: Clinical trial NCT06633016 is currently recruiting participants. This phase2 study for major depressive disorder is actively seeking new participants at 50 locations across the United States. The study is sponsored by Autobahn Therapeutics, Inc.. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT06633016 is actively recruiting participants as of August 28, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 50 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT06633016 was last updated Jan 20, 2026 (January 20, 2026). HelloStudys verifies this status automatically.